BlackRock Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-4,161
| Closed | -$23K | – | 3094 |
|
|
2016
Q1 | $23K | Buy |
4,161
+1,734
| +71% | +$9.59K | ﹤0.01% | 3003 |
|
|
2015
Q4 | $42K | Sell |
2,427
-82
| -3% | -$1.42K | ﹤0.01% | 2839 |
|
|
2015
Q3 | $53K | Buy |
2,509
+610
| +32% | +$12.9K | ﹤0.01% | 2827 |
|
|
2015
Q2 | $94K | Buy |
1,899
+510
| +37% | +$25.2K | ﹤0.01% | 2743 |
|
|
2015
Q1 | $109K | Buy |
1,389
+491
| +55% | +$38.5K | ﹤0.01% | 2630 |
|
|
2014
Q4 | $54K | Buy |
+898
| New | +$54K | ﹤0.01% | 2765 |
|